Skip to content
Screener

Opus Genetics IRD Enterprise value

Enterprise value at other companies

AbbVie logo
AbbVieABBV
$460.96B+24.7%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$696.49M+26.9%
Regenxbio logo
RegenxbioRGNX
$651.8M+51.8%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$423.34M+961%
Opko Health logo
Opko HealthOPK
$1.18B+9.8%
uniQure logo
uniQureQURE
$2.82B+376%

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M—
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$304.5M+381%
P/S25.4×+21.3×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×—
Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

$323.7Mmarket cap+$1.2Mtotal debt−$60.0Mcash and equivalents=$264.97M

The source filing: Opus Genetics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 4:03 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-034084

FAQ

What is Opus Genetics's enterprise value?
Opus Genetics (IRD) reported enterprise value of $264.97M in Q1 2026.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Ask your AI about Opus Genetics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude